Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial.
Zafeiropoulos S, Farmakis I, Kartas A, Arvanitaki A, Pagiantza A, Boulmpou A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Vlachou A, Arvanitakis K, Miyara SJ, Ziakas A, Molmenti EP, Kassimis G, Zanos S, Karvounis H, Giannakoulas G. Zafeiropoulos S, et al. Among authors: kosmidis d. Atherosclerosis. 2021 Apr;323:37-43. doi: 10.1016/j.atherosclerosis.2021.03.013. Epub 2021 Mar 17. Atherosclerosis. 2021. PMID: 33780749 Clinical Trial.
Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome.
Farmakis I, Zafeiropoulos S, Pagiantza A, Boulmpou A, Arvanitaki A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Karvounis H, Giannakoulas G. Farmakis I, et al. Among authors: kosmidis d. Eur J Prev Cardiol. 2020 Dec;27(19):2314-2317. doi: 10.1177/2047487319891780. Epub 2019 Dec 9. Eur J Prev Cardiol. 2020. PMID: 31818140 No abstract available.
Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome.
Zafeiropoulos S, Farmakis I, Kartas A, Arvanitaki A, Pagiantza A, Boulmpou A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Arvanitakis K, Sianos G, Makedou K, Ziakas A, Tzikas A, Karvounis H, Giannakoulas G. Zafeiropoulos S, et al. Among authors: kosmidis d. Am J Cardiol. 2020 Oct 15;133:7-14. doi: 10.1016/j.amjcard.2020.07.046. Epub 2020 Jul 28. Am J Cardiol. 2020. PMID: 32828524
Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study.
Kartas A, Doundoulakis I, Ntiloudi D, Koutsakis A, Kosmidis D, Rampidis G, Apostolopoulou S, Frogoudaki A, Tzifa A, Avramidis D, Ntzoyvara O, Liori S, Mousiama T, Mouratoglou SA, Karvounis H, Giannakoulas G. Kartas A, et al. Among authors: kosmidis d. BMJ Open. 2020 Sep 22;10(9):e038012. doi: 10.1136/bmjopen-2020-038012. BMJ Open. 2020. PMID: 32963069 Free PMC article.
The Adult Congenital Heart Disease Anatomic and Physiological Classification: Associations with Clinical Outcomes in Patients with Atrial Arrhythmias.
Kartas A, Papazoglou AS, Kosmidis D, Moysidis DV, Baroutidou A, Doundoulakis I, Despotopoulos S, Vrana E, Koutsakis A, Rampidis GP, Ntiloudi D, Liori S, Mousiama T, Avramidis D, Apostolopoulou S, Frogoudaki A, Tzifa A, Karvounis H, Giannakoulas G. Kartas A, et al. Among authors: kosmidis d. Diagnostics (Basel). 2022 Feb 11;12(2):466. doi: 10.3390/diagnostics12020466. Diagnostics (Basel). 2022. PMID: 35204557 Free PMC article.
The spectrum of COVID-19 in complex adult congenital heart disease: A case series.
Farmakis I, Kosmidis D, Liantzakis C, Serasli E, Karvounis H, Koutsakis A, Giannakoulas G. Farmakis I, et al. Among authors: kosmidis d. Int J Cardiol Congenit Heart Dis. 2021 May;3:100097. doi: 10.1016/j.ijcchd.2021.100097. Epub 2021 Feb 18. Int J Cardiol Congenit Heart Dis. 2021. PMID: 35359462 Free PMC article. No abstract available.
Association of Health Status Metrics with Clinical Outcomes in Patients with Adult Congenital Heart Disease and Atrial Arrhythmias.
Baroutidou A, Kartas A, Papazoglou AS, Kosmidis D, Moysidis DV, Otountzidis N, Doundoulakis I, Despotopoulos S, Vrana E, Koutsakis A, Rampidis GP, Ntiloudi D, Liori S, Avramidis D, Karagiannidis E, Nikolopoulos TT, Apostolopoulou S, Frogoudaki A, Tzifa A, Karvounis H, Giannakoulas G. Baroutidou A, et al. Among authors: kosmidis d. J Clin Med. 2022 Oct 20;11(20):6181. doi: 10.3390/jcm11206181. J Clin Med. 2022. PMID: 36294501 Free PMC article.
Use of apixaban in adults with congenital heart disease and atrial arrhythmias: The PROTECT-AR study.
Kartas A, Papazoglou AS, Moysidis DV, Despotopoulos S, Baroutidou A, Kosmidis D, Koutsakis A, Liori S, Apostolopoulou S, Frogoudaki A, Tzifa A, Galatas A, Alexandridis G, Spiridonidis E, Doundoulakis I, Karagiannidis E, Karvounis H, Ziakas A, Giannakoulas G. Kartas A, et al. Among authors: kosmidis d. Int J Cardiol. 2024 Jul 1;406:131993. doi: 10.1016/j.ijcard.2024.131993. Epub 2024 Mar 31. Int J Cardiol. 2024. PMID: 38565389 Free article.
Frailty and Cognitive Function in Middle-Aged and Older Adults With Congenital Heart Disease.
Daelman B, Van Bulck L, Luyckx K, Kovacs AH, Van De Bruaene A, Ladouceur M, Yang HL, Moon JR, Schmidt A, Lykkeberg B, Callus E, de Hosson M, Sandberg C, Johansson B, Hlebowicz J, Areias ME, Amedro P, Coats L, Mandalenakis Z, Kaneva A, Moons P, Goossens E; APPROACH-IS II consortium; International Society for Adult Congenital Heart Disease. Daelman B, et al. J Am Coll Cardiol. 2024 Mar 26;83(12):1149-1159. doi: 10.1016/j.jacc.2024.01.021. J Am Coll Cardiol. 2024. PMID: 38508848
21 results